S&P 500 Futures
(-0.08%) 5 304.25 points
Dow J Futures
(-0.09%) 40 140 points
Nasdaq Futures
(-0.05%) 18 465 points
Oil
(-0.07%) $83.11
Gas
(-0.62%) $1.752
Gold
(0.73%) $2 254.80
Silver
(0.74%) $25.10
Platinum
(0.21%) $923.00
USD/EUR
(0.07%) $0.927
USD/NOK
(0.30%) $10.87
USD/GBP
(0.07%) $0.793
USD/RUB
(-0.32%) $92.28

Realtime updates for Lipum AB (publ) [LIPUM.ST]

Exchange: STO Sector: Healthcare Industry: Biotechnology
Last Updated28 Mar 2024 @ 07:12

-0.30% SEK 6.74

Live Chart Being Loaded With Signals

Commentary (28 Mar 2024 @ 07:12):

Warning: Trying to access array offset on null in /home/getagraph/public_html/stock.php on line 302

Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of pediatric rheumatism and rheumatoid arthritis diseases...

Stats
Today's Volume 259.00
Average Volume 10 769.00
Market Cap 62.78M
EPS SEK0 ( 2023-10-31 )
Last Dividend SEK0 ( N/A )
Next Dividend SEK0 ( N/A )
P/E -1.520
ATR14 SEK0 (0.00%)

Lipum AB (publ) Correlation

10 Most Positive Correlations
10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Lipum AB (publ) Financials

Annual 2022
Revenue: SEK0
Gross Profit: SEK-11 000.00 (0.00 %)
EPS: SEK-6.02
Q3 2023
Revenue: SEK115 000
Gross Profit: SEK102 000 (88.70 %)
EPS: SEK-0.710
Q2 2023
Revenue: SEK0
Gross Profit: SEK0 (0.00 %)
EPS: SEK-1.820
Q1 2023
Revenue: SEK0
Gross Profit: SEK-3 000.00 (0.00 %)
EPS: SEK-0.940

Financial Reports:

No articles found.

Lipum AB (publ)

Lipum AB (publ), a biopharmaceutical company, engages in the discovery and development of treatment for chronic inflammatory diseases in Sweden. It is developing SOL-116, a humanized antibody that is in late preclinical phase for the treatment of pediatric rheumatism and rheumatoid arthritis diseases. Lipum AB (publ) has a collaboration with Pelago Bioscience AB to focus on drug target monitoring during clinical studies of the lead candidate SOL-116. The company was founded in 2010 and is headquartered in Umeå, Sweden.

About Live Signals

The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.

The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators